Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Founded Date:
2015-01-01
Last Funding Type:
Series B
Headquarters:
Taipei, T'ai-pei, Taiwan
Investors Number:
4
Technology:
diagnostics
Employee Number:
11-50
Industry:
Biotechnology, Health Care, Life Science
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-02-26
Funding Status:
Early Stage Venture
Total Funding:
$10M